Molecular Typing of Streptococcus agalactiae- cMLSB Phenotype Isolates by Enterobacterial Repetitive Intergenic Consensus-PCR (ERIC-PCR) in Isfahan, Iran

Document Type : Original Research

Authors
1 Department of Microbiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
2 Department of Microbiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
3 Department of Microbiology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
Abstract
Backgrounds: Group B Streptococcus (GBS) is an important opportunistic bacterial pathogen that could cause serious infections, especially in neonates, adults, and the elderly. In GBS isolates, a macrolide resistance phenotype that confers constitutive resistance to macrolide-lincosamide-streptogramin B antibiotics (cMLSB phenotype) has become a global concern. On the other hand, little is known about the genetic relatedness and diversity of GBS isolates isolated from various patients in Iran. Hence, this study aimed to determine the genetic relatedness and molecular typing of cMLSB-GBS isolates using enterobacterial repetitive intergenic consensus-PCR (ERIC- PCR) technique.

Materials & Methods: A total of 100 GBS isolates were collected from patients with urinary tract infections (UTI). Among them, 52 erythromycin-resistant GBS isolates were selected, and double-disc diffusion (D-zone) technique was applied to determine the MLSB phenotype among the isolates based on CLSI criteria. Then the genetic relatedness of MLSB-GBS isolates was assessed using ERIC-PCR fingerprinting method.

Findings: Among 52 erythromycin-resistant GBS isolates, 38 isolates were identified with cMLSB phenotype, nine isolates with M phenotype, and five isolates with iMLSB phenotype. The analysis of ERIC-PCR patterns revealed eight different ERIC types that were divided into seven clusters (A-G) and one single type. Also, four isolates were non-typeable. ERIC type A/ serotype Ib was the most prevalent clone among the isolates.

Conclusion: The current study findings showed a high level of diversity and multiclonal spread of the cMLSB phenotype in Isfahan. ERIC type A/ serotype Ib is the predominant clone circulating among erythromycin-resistant GBS strains.

Keywords

Subjects


1. Raabe VN, Shane AL. Group B streptococcus (Streptococcus agalactiae). Gram‐Positive Pathogens. 2019:228-38.
2. Johansen NR, Kjærbye-Thygesen A, Jønsson S, Westh H, Nilas L, Rørbye C. Prevalence and treatment of group B streptococcus colonization based on risk factors versus intrapartum culture screening. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2019;240:178-81.
3. Mukesi M, Iweriebor BC, Obi LC, Nwodo UU, Moyo SR, Okoh AI. Prevalence and capsular type distribution of Streptococcus agalactiae isolated from pregnant women in Namibia and South Africa. BMC infectious diseases. 2019;19(1):1-7.
4. Pietrocola G, Arciola CR, Rindi S, Montanaro L, Speziale P. Streptococcus agalactiae non-pilus, cell wall-anchored proteins: involvement in colonization and pathogenesis and potential as vaccine candidates. Frontiers in immunology. 2018;9:602.
5. Kline KA, Schwartz DJ, Lewis WG, Hultgren SJ, Lewis AL. Immune activation and suppression by group B streptococcus in a murine model of urinary tract infection. Infection and immunity. 2011;79(9):3588-95.
6. Tan CK, Ulett KB, Steele M, Benjamin WH, Ulett GC. Prognostic value of semi-quantitative bacteruria counts in the diagnosis of group B streptococcus urinary tract infection: a 4-year retrospective study in adult patients. BMC infectious diseases. 2012;12(1):273.
7. Leclercq SY, Sullivan MJ, Ipe DS, Smith JP, Cripps AW, Ulett GC. Pathogenesis of Streptococcus urinary tract infection depends on bacterial strain and β-hemolysin/cytolysin that mediates cytotoxicity, cytokine synthesis, inflammation and virulence. Scientific reports. 2016;6(1):1-14.
8. Garland SM, Cottrill E, Markowski L, Pearce C, Clifford V, Ndisang D, et al. Antimicrobial resistance in group B streptococcus: the Australian experience. Journal of medical microbiology. 2011;60(2):230-5.
9. Gizachew M, Tiruneh M, Moges F, Adefris M, Tigabu Z, Tessema B. Streptococcus agalactiae from Ethiopian pregnant women; prevalence, associated factors and antimicrobial resistance: alarming for prophylaxis. Annals of clinical microbiology and antimicrobials. 2019;18(1):3.
10. Vandana K, Singh J, Chiranjay M, Bairy I. Inducible clindamycin resistance in Staphylococcus aureus: Reason for treatment failure. Journal of global infectious diseases. 2009;1(1):76.
11. Yao K, Poulsen K, Maione D, Rinaudo CD, Baldassarri L, Telford JL, et al. Capsular gene typing of Streptococcus agalactiae compared to serotyping by latex agglutination. Journal of clinical microbiology. 2013;51(2):503-7.
12. Poyart C, Tazi A, Réglier-Poupet H, Billoët A, Tavares N, Raymond J, et al. Multiplex PCR assay for rapid and accurate capsular typing of group B streptococci. Journal of clinical microbiology. 2007;45(6):1985-8.
13. Martinez G, Harel J, Higgins R, Lacouture S, Daignault D, Gottschalk M. Characterization of Streptococcus agalactiae isolates of bovine and human origin by randomly amplified polymorphic DNA analysis. J Clin Microbiol. 2000;38(1):71-8.
14. Ibarz Pavón AB, Maiden MC. Multilocus sequence typing. Methods in molecular biology (Clifton, NJ). 2009;551:129-40.
15. Sharma-Kuinkel BK, Rude TH, Fowler VG. Pulse field gel electrophoresis. Methods Mol Biol. 2016;1373:117-30.
16. Zhang G, Kotiw M, Daggard G. A RAPD‐PCR genotyping assay which correlates with serotypes of group B streptococci. Letters in applied microbiology. 2002;35(3):247-50.
17. Qasem J, Al-Mouqati S, Al-Shamalli A, Al-Sharifi F, Solman S. Application of random amplification of polymorphic DNA, antibiogram and serotyping for differentiating Streptococcus agalactiae clinical and environmental isolates from Kuwait. Research Journal of Microbiology. 2009;4(1):1-12.
18. Kosek M, Yori PP, Gilman RH, Vela H, Olortegui MP, Chavez CB, et al. Facilitated molecular typing of Shigella isolates using ERIC-PCR. The American journal of tropical medicine and hygiene. 2012;86(6):1018-25.
19. Wilson LA, Sharp PM. Enterobacterial repetitive intergenic consensus (ERIC) sequences in Escherichia coli: Evolution and implications for ERIC-PCR. Molecular biology and evolution. 2006;23(6):1156-68.
20. Hulton C, Higgins C, Sharp P. ERIC sequences: a novel family of repetitive elements in the genomes of Escherichia coli, Salmonella typhimurium and other enterobacteria. Molecular microbiology. 1991;5(4):825-34.
21. Tsai M-H, Hsu J-F, Lai M-Y, Lin L-C, Chu S-M, Huang H-R, et al. Molecular Characteristics and Antimicrobial Resistance of Group B Streptococcus Strains Causing Invasive Disease in Neonates and Adults. Frontiers in microbiology. 2019;10(264).
22. Castor ML, Whitney CG, Como-Sabetti K, Facklam RR, Ferrieri P, Bartkus JM, et al. Antibiotic Resistance Patterns in Invasive Group B Streptococcal Isolates. Infectious Diseases in Obstetrics and Gynecology. 2008;2008:727505.
23. Gizachew M, Tiruneh M, Moges F, Tessema B. Streptococcus agalactiae maternal colonization, antibiotic resistance and serotype profiles in Africa: a meta-analysis. Annals of Clinical Microbiology and Antimicrobials. 2019;18(1):14.
24. Jalalifar S, Havaei SA, Motallebirad T, Moghim S, Fazeli H, Esfahani BN. Determination of surface proteins profile, capsular genotyping, and antibiotic susceptibility patterns of Group B Streptococcus isolated from urinary tract infection of Iranian patients. BMC research notes. 2019;12(1):1-6.
25. Khan AS, Walsh A, Crowley B. Role of efflux in macrolide resistance in β-haemolytic streptococci of groups A, B, C and G collected in an Irish teaching hospital. Journal of medical microbiology. 2011;60(2):262-4.
26. Green MR, Sambrook J. Isolation of high-molecular-weight DNA using organic solvents. Cold Spring Harbor Protocols. 2017;2017(4):pdb. prot093450.
27. Bishi D, Verghese S, Verma R. Molecular typing of colonizing Streptococcus agalactiae strains by enterobacterial repetitive intergenic consensus PCR (ERIC-PCR) in a Chennai based hospital. Indian journal of microbiology. 2008;48(2):291-6.
28. Heidari H, Halaji M, Taji A, Kazemian H, Abadi MSS, Sisakht MT, et al. Molecular analysis of drug-resistant Acinetobacter baumannii isolates by ERIC-PCR. Meta Gene. 2018;17:132-5.
29. Heras J, Domínguez C, Mata E, Pascual V, Lozano C, Torres C, et al. GelJ–a tool for analyzing DNA fingerprint gel images. BMC bioinformatics. 2015;16(1):1-8.
30. Russell NJ, Seale AC, O’Driscoll M, O’Sullivan C, Bianchi-Jassir F, Gonzalez-Guarin J, et al. Maternal colonization with group B Streptococcus and serotype distribution worldwide: systematic review and meta-analyses. Clinical infectious diseases. 2017;65(suppl_2):S100-S11.
31. Hayes K, O’Halloran F, Cotter L. A review of antibiotic resistance in Group B Streptococcus: the story so far. Critical Reviews in Microbiology. 2020:1-17.
32. Lu B, Chen X, Wang J, Wang D, Zeng J, Li Y, et al. Molecular characteristics and antimicrobial resistance in invasive and noninvasive Group B Streptococcus between 2008 and 2015 in China. Diagnostic microbiology and infectious disease. 2016;86(4):351-7.
33. Khodaei F, Najafi M, Hasani A, Kalantar E, Sharifi E, Amini A, et al. Pilus–encoding islets in S. agalactiae and its association with antibacterial resistance and serotype distribution. Microbial pathogenesis. 2018;116:189-94.
34. Bergal A, Loucif L, Benouareth D, Bentorki A, Abat C, Rolain J-M. Molecular epidemiology and distribution of serotypes, genotypes, and antibiotic resistance genes of Streptococcus agalactiae clinical isolates from Guelma, Algeria and Marseille, France. European Journal of Clinical Microbiology & Infectious Diseases. 2015;34(12):2339-48.
35. Diekema DJ, Andrews JI, Huynh H, Rhomberg PR, Doktor SR, Beyer J, et al. Molecular epidemiology of macrolide resistance in neonatal bloodstream isolates of group B streptococci. Journal of clinical microbiology. 2003;41(6):2659-61.
36. Morozumi M, Wajima T, Kuwata Y, Chiba N, Sunaoshi K, Sugita K, et al. Associations between capsular serotype, multilocus sequence type, and macrolide resistance in Streptococcus agalactiae isolates from Japanese infants with invasive infections. Epidemiology & Infection. 2014;142(4):812-9.
37. Domelier A-S, van der Mee-Marquet N, Arnault L, Mereghetti L, Lanotte P, Rosenau A, et al. Molecular characterization of erythromycin-resistant Streptococcus agalactiae strains. Journal of Antimicrobial Chemotherapy. 2008;62(6):1227-33.
38. Guo D, Cao X, Li S, Ou Q, Lin D, Yao Z, et al. Neonatal colonization of group B Streptococcus in China: prevalence, antimicrobial resistance, serotypes, and molecular characterization. American Journal of Infection Control. 2018;46(3):e19-e24.
39. Furfaro LL, Chang BJ, Payne MS. Perinatal Streptococcus agalactiae epidemiology and surveillance targets. Clinical microbiology reviews. 2018;31(4):e00049-18.
40. Hall J, Adams NH, Bartlett L, Seale AC, Lamagni T, Bianchi-Jassir F, et al. Maternal Disease With Group B Streptococcus and Serotype Distribution Worldwide: Systematic Review and Meta-analyses. Clinical Infectious Diseases. 2017;65(suppl_2):S112-S24.